More fill volume, higher viscosity: Modern active ingredients (APIs) put totally new demands on syringes. With Needle-Trap, Schreiner MediPharm offers a unique label-based needle protection system that now is also available for large-volume syringes. The further development of Needle-Trap combines safety, cost efficiency, and sustainability.

Biologics and biosimilars are becoming increasingly important, with large-volume syringes up to 5 ml frequently being used for the highly viscous APIs with larger molecular structures. At the same time, the protection against needlestick injuries for users and healthcare staff remains indispensable. A protection that needs to be adapted to the changed requirements to achieve smooth processability in manufacturing environments and reliable functionality in final use.

Further Development for Larger Syringe Sizes
Schreiner MediPharm has subjected the proven Needle-Trap needle protection system to further development specifically for use with 2.25-ml-, 3-ml-, and 5-ml-syringes. Design and function of the label with an integrated needle trap have been adapted to the specific requirements of large-volume syringes. Extensive tests ensure that the needle protection label can be produced both with process stability at Schreiner MediPharm and reliably dispensed on systems in pharmaceutical manufacturing environments.

Sustainable, Efficient, and User-Friendly
The new version retains the special benefits of Needle-Trap. Compared to conventional needle protection systems or autoinjectors, the compact label design enables significant savings in terms of material consumption, costs, and CO₂ emissions. In addition, pharmaceutical manufacturers benefit from smooth integration into existing processes while end users are provided with ease of use and reliable protection against needlestick injuries. The innovative evolution is suitable for use with novel drugs and offers further potential for a cost-efficient and sustainable pharmaceutical supply chain.